UK launches £45m AI drive against drug‑resistant superbugs
The UK has announced a £45 million partnership between the Fleming Initiative and GSK to apply artificial intelligence to the accelerating global threat of drug‑resistant infections. Launched in 2025, the programme targets six research areas, with an early focus on hard‑to‑treat Gram‑negative bacteria and emerging fungal threats such as Aspergillus. Project leaders say the aim … Read more